The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biologic Therapeutics-Global Market Insights and Sales Trends 2024
Synopsis
Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
The global Biologic Therapeutics market size is expected to reach US$ 851340 million by 2029, growing at a CAGR of 9.6% from 2023 to 2029. The market is mainly driven by the significant applications of Biologic Therapeutics in various end use industries. The expanding demands from the Rheumatoid Arthritis, Anemia, Cancer and Diabetes, are propelling Biologic Therapeutics market. Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Blood Products segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biologic Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biologic Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biologic Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biologic Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biologic Therapeutics covered in this report include Pfizer, Novartis Global, AstraZeneca, Merck, GlaxoSmithKline and Aurobindo Pharma, etc.
The global Biologic Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Novartis Global
AstraZeneca
Merck
GlaxoSmithKline
Aurobindo Pharma
Global Biologic Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biologic Therapeutics market, Segment by Type:
Vaccines
Blood Products
Allergenic Extracts
Human Cells and Tissues
Gene Therapies
Protein
Cellular Therapies
Xenotransplantation Products
Global Biologic Therapeutics market, by Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biologic Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
The global Biologic Therapeutics market size is expected to reach US$ 851340 million by 2029, growing at a CAGR of 9.6% from 2023 to 2029. The market is mainly driven by the significant applications of Biologic Therapeutics in various end use industries. The expanding demands from the Rheumatoid Arthritis, Anemia, Cancer and Diabetes, are propelling Biologic Therapeutics market. Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Blood Products segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biologic Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biologic Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biologic Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biologic Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biologic Therapeutics covered in this report include Pfizer, Novartis Global, AstraZeneca, Merck, GlaxoSmithKline and Aurobindo Pharma, etc.
The global Biologic Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Novartis Global
AstraZeneca
Merck
GlaxoSmithKline
Aurobindo Pharma
Global Biologic Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biologic Therapeutics market, Segment by Type:
Vaccines
Blood Products
Allergenic Extracts
Human Cells and Tissues
Gene Therapies
Protein
Cellular Therapies
Xenotransplantation Products
Global Biologic Therapeutics market, by Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biologic Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Biologic Therapeutics
1.1 Biologic Therapeutics Market Overview
1.1.1 Biologic Therapeutics Product Scope
1.1.2 Biologic Therapeutics Market Status and Outlook
1.2 Global Biologic Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Biologic Therapeutics Market Size by Region (2018-2029)
1.4 Global Biologic Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Biologic Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Biologic Therapeutics Market Size (2018-2029)
1.6.1 North America Biologic Therapeutics Market Size (2018-2029)
1.6.2 Europe Biologic Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Biologic Therapeutics Market Size (2018-2029)
1.6.4 Latin America Biologic Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Biologic Therapeutics Market Size (2018-2029)
2 Biologic Therapeutics Market by Type
2.1 Introduction
2.1.1 Vaccines
2.1.2 Blood Products
2.1.3 Allergenic Extracts
2.1.4 Human Cells and Tissues
2.1.5 Gene Therapies
2.1.6 Protein
2.1.7 Cellular Therapies
2.1.8 Xenotransplantation Products
2.2 Global Biologic Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Biologic Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Biologic Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Biologic Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Biologic Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Biologic Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Biologic Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Biologic Therapeutics Revenue Breakdown by Type (2018-2029)
3 Biologic Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Rheumatoid Arthritis
3.1.2 Anemia
3.1.3 Cancer
3.1.4 Diabetes
3.1.5 Others
3.2 Global Biologic Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Biologic Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Biologic Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Biologic Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Biologic Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Biologic Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Biologic Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Biologic Therapeutics Revenue Breakdown by Application (2018-2029)
4 Biologic Therapeutics Competition Analysis by Players
4.1 Global Biologic Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biologic Therapeutics as of 2022)
4.3 Date of Key Players Enter into Biologic Therapeutics Market
4.4 Global Top Players Biologic Therapeutics Headquarters and Area Served
4.5 Key Players Biologic Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Biologic Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Biologic Therapeutics Products, Services and Solutions
5.1.4 Pfizer Biologic Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Novartis Global
5.2.1 Novartis Global Profile
5.2.2 Novartis Global Main Business
5.2.3 Novartis Global Biologic Therapeutics Products, Services and Solutions
5.2.4 Novartis Global Biologic Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis Global Recent Developments
5.3 AstraZeneca
5.3.1 AstraZeneca Profile
5.3.2 AstraZeneca Main Business
5.3.3 AstraZeneca Biologic Therapeutics Products, Services and Solutions
5.3.4 AstraZeneca Biologic Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Biologic Therapeutics Products, Services and Solutions
5.4.4 Merck Biologic Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Recent Developments
5.5 GlaxoSmithKline
5.5.1 GlaxoSmithKline Profile
5.5.2 GlaxoSmithKline Main Business
5.5.3 GlaxoSmithKline Biologic Therapeutics Products, Services and Solutions
5.5.4 GlaxoSmithKline Biologic Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 GlaxoSmithKline Recent Developments
5.6 Aurobindo Pharma
5.6.1 Aurobindo Pharma Profile
5.6.2 Aurobindo Pharma Main Business
5.6.3 Aurobindo Pharma Biologic Therapeutics Products, Services and Solutions
5.6.4 Aurobindo Pharma Biologic Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Aurobindo Pharma Recent Developments
6 North America
6.1 North America Biologic Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Biologic Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biologic Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biologic Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biologic Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biologic Therapeutics Market Dynamics
11.1 Biologic Therapeutics Industry Trends
11.2 Biologic Therapeutics Market Drivers
11.3 Biologic Therapeutics Market Challenges
11.4 Biologic Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
